openPR Logo
Press release

Global Anti-Viral Drug Market will multiply at an impressive USD 42.3 Billion by 2024 & Top Key Players GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Abbott Laboratories, Cipla Limited, F.Hoffmann-La Roche Ltd., Bristol-Myers-Squibb, Gilead Scien

07-27-2018 02:59 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Nester Pvt Ltd

/ PR Agency: Research Nester
Global Anti-Viral Drug Market will multiply at an impressive USD

“Anti-Viral Drug Market: Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation”

The anti-viral drug market has been segmented by type into generic drugs and branded drugs. Among these segments, the generic drugs segment dominated the anti-viral drug market by holding the highest market share in previous year and is anticipated to continue its dominance with highest compound annual growth rate over the period 2017-2024.

Global Anti-viral Drug Market accounted for USD 31.2 Billion in 2016 and is projected to garner USD 42.3 Billion by the end of 2024, expanding at a compound annual growth rate of 5.9% over the forecast period. Rising prevalence of viral infections and diseases across the globe is expected to increase the demand for anti-viral drugs globally which will further the growth of anti-viral drugs market by noteworthy revenue by the end of 2024.

Request Report Sample @ https://www.researchnester.com/sample-request/2/rep-id-473

In regional segment, North America dominated the overall market of anti-viral drugs in 2016 and is further expected to continue its dominance over the forecast period on the account of rising healthcare expenditure. The United States is expected to be the major contributor to the growth of anti-viral drugs owing to the presence of major key players in this region. Additionally, presence of highly developed healthcare infrastructure and rising awareness about the viral infections is expected to fuel the growth of anti-viral drugs market in the North America region. Factors such as rising disposable income, increasing number of virus infected people combined with rising medical tourism is anticipated to drive the anti-viral drug market in Asia-Pacific region. Further, favorable government regulations boosting the growth of healthcare sector is likely to swell the demand for anti-viral drugs in this region.

Rise in Anti-Viral Drugs with Growing HIV Cases

According to WHO, the number of people infected with HIV were estimated to be 36.7 Million in 2016. Additionally, 1.8 Million new cases of HIV were registered in 2016. Rising number of HIV cases is expected to be one of the key growth drivers for anti-viral drugs market. Further, rising awareness about this deadly disease is substantially raising the demand for the anti-viral drugs globally. These factors are expected to benefit the expansion of anti-viral drug market. However, lack of awareness about viral diseases and high-cost of advanced developing anti-viral drugs is likely to inhibit the growth of the anti-viral drugs market in the near future.

Request for TOC Here @ https://www.researchnester.com/toc-request/1/rep-id-473

The report titled “Anti-Viral Drug Market: Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation” delivers detailed overview of the anti-viral drugs market in terms of market segmentation by type, by application, by end-user and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

For more details visit @ https://www.researchnester.com/reports/anti-viral-drug-market-global-historical-growth-2012-2016-future-outlook-2017-2024-demand-analysis-opportunity-evaluation/473

This report also provides the existing competitive scenario of some of the key players of the anti-viral drugs market which includes company profiling of GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Abbott Laboratories, Cipla Limited, F.Hoffmann-La Roche Ltd., Bristol-Myers-Squibb, Gilead Sciences, Aurobindo Pharma and Sino Biopharmaceutical. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the anti-viral drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Buy This Premium Reports Now @ https://www.researchnester.com/payment/rep-id-473

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Follow Us LinkedIn @ https://www.linkedin.com/company/research-nester-pvt.-ltd./

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Viral Drug Market will multiply at an impressive USD 42.3 Billion by 2024 & Top Key Players GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Abbott Laboratories, Cipla Limited, F.Hoffmann-La Roche Ltd., Bristol-Myers-Squibb, Gilead Scien here

News-ID: 1150461 • Views:

More Releases from Research Nester Pvt Ltd

Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2017-2024
Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions An …
The chemical fertilizers market has been segmented into macronutrients, micronutrients, application and forms. Based on macronutrients, the market has been segmented into nitrogen based fertilizers, phosphate based fertilizers and potash based fertilizers. Among these segments, the nitrogen based fertilizers are estimated to dominate the market by holding the largest share of approximately 50%. This can be attributed to the absorption of nitrogen by plants. In 2013, the demand for nitrogen
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2027
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Prod …
The global glass coating market is segmented by coating type into pyrolytic coating, magnetic sputtering coating and sol-gel coating; by technology into liquid glass coating and nano glass coating; by application into construction, paints & coating, automotive, aviation and others and by regions. According to Federal Reserve Bank of Chicago represents increase in sales of light vehicle in China by 2.1%, Latin America by 6.2%, Europe by 2.6%, and Rest
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2019-2027
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And To …
The global insect repellent market is segmented by repellent type into coils, liquid vaporizers, sprays/aerosol, mats, cream and oil; by ingredient into natural and synthetic; by sales channel into online and offline and by regions. The insect repellent market is anticipated to mask a CAGR of 8.3% during the forecast period i.e. 2019-2027. The rising penetration of insect repellents in untapped rural markets across the developing countries as well as
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2027
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, De …
The global waterproofing market is segmented on the basis of type, application and end-use. The market is segmented on the basis of type, it is segmented into Bitumen, PVC, TPO and EPDM. Bitumen leads the product segment in 2017 on the account of superior properties which include high viscosity, resistance to UV light and better binding nature. On the basis of application, it is segmented into Roofing and Walls, Flooring,

All 4 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase